Gut microbiota: in sickness and in health by Michán Doña, Carmen Maria & Huertas Romera, María Jose
Highlight
Gut microbiota: in sickness and in health
M. José Huertas1 and Carmen Michán2*
1Instituto de Bioquímica Vegetal y Fotosíntesis, Centro
de Investigaciones Isla de la Cartuja, Universidad de
Sevilla-CSIC, Av. Américo Vespucio 49, 41092, Seville,
Spain.
2Campus de Rabanales, Department of Biochemistry
and Molecular Biology, Universidad de Córdoba, Edificio
Severo Ochoa C-6, 2a Planta, 14071, Córdoba, Spain.
At birth, the human colon is rapidly colonized by a vast
amount of gut microbes that affect host physiology and
metabolism because of their ability to ferment nutrients
and secrete bioactive compounds (de Vos, 2013). Lately,
different reports are exploring their potential use for the
treatment of a wide variety of diseases, although the
clinical use of the gut microbiota is not all that innovative,
since detailed faecal therapies for the treatment of
abdominal pains were documented by Ming dynasty
Chinese doctors, over 1000 years ago (Zhang et al.,
2012). Researchers are now working on how faecal
micro-organisms contribute to diseases, particularly in the
context of obesity and other related metabolic disorders or
ageing.
Several publications analyse the differences in compo-
sition and/or activity of the gut microbiota of slim vs. fat
individuals, proposing that only few bacterial genera are
associated with obesity, swelling and associated meta-
bolic disorders, both in humans and rodents. But the main
difficulty in determining these relationships is the fluctua-
tion of microbial community configuration among unre-
lated individuals. We highlight an article published in
Science (Ridaura et al., 2013) because of its smart
approach. The authors describe the transplantation of
faecal microbiota from several pairs of human twins, an
obese and a slim one, into germ-free mice. The rodents
that received the obese twin’s faecal microbiota notice-
ably increased their adipose mass compared with the
receptors of the slim twin’s microbiota. Furthermore,
cohousing of mice harbouring ‘obese’ microbiota along
with mice harbouring a ‘slim’ one, prevented high body
mass and obesity in the first group, which the authors
attributed to a directional transfer of microbes. Also, this
invasion of beneficial bacteria seems to depend on food
intake because obesity was not prevented when obese
mice harbouring a ‘slim’ microbiota ate a high-fat/low-fibre
diet (Ridaura et al., 2013).
The importance of diet on the establishment of the gut
flora meets the results of a long-term study on intestinal
microbiota published in Environmental Microbiology
showing that, although adults gut microbiota profiles are
unique and mostly stable, diet, together with the use of
antibiotics, intestinal transit and lifestyle clearly alter
their proportions (Rajilic´-Stojanovic´ et al., 2013). These
authors designed a comprehensible and highly reproduc-
ible phylogenetic microarray, the human intestinal tract
chip, to analyse faecal samples of young adults gathered
for several years and identifying subject-specific
microbiota profiles preserved over time. They also
showed how changes in environmental conditions are
associated with changes in the abundance of certain
species/genera of this microbiota. The challenge now is to
link specific metabolic disorders to their corresponding gut
microbiota alterations.
This question has also been addressed in a Nature
article that reports the correlation between diversity of
gut microbial genes, metabolic markers (e.g., body
weight, fat mass, glucose and lipid metabolism, inflam-
mation) and susceptibility to lose weight upon dietary
restrictions (Cotillard et al., 2013). Using a quantitative
metagenomics approach, Cotillard et al. proposed a
bimodal distribution of microbial genes: low gene count
(LGC) and high gene count (HGC). Individuals with a
LGC showed increased weight, adiposity, insulin resist-
ance and inflammatory diseases over time compared
with HGC individuals. Additionally, and in agreement with
the work by (Rajilic´-Stojanovic´ et al., 2013), individuals
with a LGC also exhibited specific microbial genera
known to be linked to inflammatory diseases or altered
gut barrier function. The authors concluded that individ-
uals with LGC exhibited metabolic disorders and sug-
gested that microbial gene wealth may be enhanced by
dietary intervention. In the near future, these parameters
may be used as biomarkers for the prognosis of obesity-
related diseases.
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Another current issue is the relationship between gut
microbiota and human ageing that Harald Brüssow has
recently reviewed in Microbial Biotechnology, in view of
the classic book ‘The Prolongation of Life’ by Metchnikoff
(1907), and the ELDERMET project that pursues health
improvement of elderly people via modification of their gut
flora (Brüssow, 2013a). All the reviewed studies show
constraints that prevent from drawing a clear conclusion:
small samples, high inter-individual variability, changing
nutritional habits among populations and/or along life or
detecting the presence of bacteria but not their viability.
Nevertheless, the decay of gut microbiota in elderly
people seems to be more related with poor diet habits and
lack of exercise, than with ageing itself. All of that work will
facilitate targeted modifications on the microbiome struc-
ture – maybe via specific food intake – that will help to
improve gut communities in the elderly as suggested by
(http://eldermet.ucc.ie/). Complementary to this report and
also in Microbial Biotechnology, Prof. Brüssow presents
an inquisitive review of the different health concepts
(Brüssow, 2013b), and discusses whether it can be meas-
ured with the appropriate tools. The author also examines
the concept of ageing – not only in humans – and how our
current knowledge may be biased by short-lived animal
studies. Although so far our life expectancy keeps
growing, biological systems are not perfect, and so
they will probably come to a point where accumulated
errors will no longer allow life, particularly on complex
organisms. If the focus is not set on increasing our life
expectancy, but rather on improving the quality of our
ageing, it would be a better choice, and the study of
the gut microbiota will undoubtedly contribute to that
improvement.
Faecal communities are crucial for health not only in
adults or seniors, but also in children, because besides
their common functions, they play an important role in the
development of their immune system (Jost et al., 2012).
Neonates’ initial colonization depends both on transfer-
ence from their mothers and on their environment, either
during birth or through close contact. Benefits from
breastfeeding include the acquisition of probiotic bacteria,
but also of other anaerobic microbes that have not been
extensively investigated yet. Jost and co-workers have
published a very revealing paper in Environmental Micro-
biology (Jost et al., 2013), establishing the correlation
between micro-organisms found in maternal faeces,
breast milk and the gut of their corresponding neonates.
The novelty of this report is that the authors not only
address the presence of the micro-organisms but also
their viability, dealing with one of the deficiencies com-
monly found in gut communities studies. Their results
clearly show divergences between both approaches.
Pyrosequencing assigns similar numbers to both mothers’
milk and faeces bacteria, but when determining ribosomal
ribonucleic acid or colony-forming unit counts, milk
samples contain more than a million-fold less microbes
than faecal ones. This report certainly supports the trans-
ference of living gut microbes from mothers to infants
through breastfeeding, although the route between the
mother’s intestines and the breasts still remains unknown.
Where does all this research lead to? Maybe the clue is
to be found in a recently published Microbial Biotechnol-
ogy review by Willem de Vos where he highlights the need
to understand how intestinal microbial communities work
to develop effective biotechnological tools for targeted
modification of gut flora (de Vos, 2013). He establishes the
concept of minimal microbiome that can be defined as the
smallest set of microbes and/or microbial functions nec-
essary to develop a stable community. Systemic analysis
of the interaction between intestinal microbes and the host
are under way and will allow the prediction of the minimal
synthetic microbiomes for the treatment of different dis-
eases. Next-generation therapies against obesity, ageing
and metabolic disorders could be based on the targeted
implementation of these microbial communities.
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